While the Elijah Cummings Lower Drug Costs Now Act would reduce drug prices, The Commonwealth Fund says the impact on prices would hinge on several key components.
A significant drop in prices, according to The Commonwealth Fund, would depend on:
- The specific choices implemented in detailed federal regulations, which could vary significantly based on a presidential administration’s policy preferences;
- The measures instituted by other countries to constrain increases in their prices; and
- The actions of pharmaceutical manufacturers intended to minimize the reduction in their revenues.
To read more on The Commonwealth Fund’s site, click here.